Encorafenib (trade name Braftovi) is a drug for the treatment of certain melanomas. it is a kinase inhibitor used to treat unresectable or metastatic melanoma with specific mutations. Reference standards of Encorafenib API,and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
stdClass Object ( [pname] => Encorafenib - API Standards [catalogue_number] => PA 05 1940000 [category_ids] => ,75,76,78,70,82, [chemical_name] => [weight] => 540.01 [form] => C22H27ClFN7O4S [cas] => 1269440-17-6 [pslug] => 1269440-17-6-encorafenib-api-pa051940000 [latest_product] => 0 [linkproducts] => 0 [offers_id] => [offers_name] => [offers_status] => [offers_start_date] => [offers_end_date] => [pageview] => [offers_slug] => [offers_product_id] => [offers_product_code] => [offers_master_id] => [offer_percentage] => [offers_product_main_cat] => )
Catalogue No.:PA 05 1940000
CAS :
Molecular Formula : C22H27ClFN7O4S
Molecular Weight : 540.01
stdClass Object ( [pname] => Encorafenib R-Isomer [catalogue_number] => PA 05 1941000 [category_ids] => ,75,76,78,70,82, [chemical_name] => [weight] => 540.01 [form] => C22H27ClFN7O4S [cas] => 1269440-29-0 [pslug] => 1269440-29-0-encorafenib-r-isomer-pa051941000 [latest_product] => 0 [linkproducts] => 0 [offers_id] => [offers_name] => [offers_status] => [offers_start_date] => [offers_end_date] => [pageview] => [offers_slug] => [offers_product_id] => [offers_product_code] => [offers_master_id] => [offer_percentage] => [offers_product_main_cat] => )
Catalogue No.:PA 05 1941000
I accept terms and conditions
Message sent successfully!! We will get back to you shortly ....
